Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double-blind, placebo-controlled, comparative study of Kynurenic acid (FS2) for the reduction of keloid scars

Next Previous
Search
Trial Profile

A double-blind, placebo-controlled, comparative study of Kynurenic acid (FS2) for the reduction of keloid scars

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Kynurenic acid (Primary)
  • Indications Keloids
  • Focus Proof of concept; Therapeutic Use

    • Most Recent Events

    • 22 Jan 2021 Results presented in a BirchBioMed Media Release.
    • 07 Mar 2019 New trial record
    • 28 Feb 2019 According to a BirchBioMed media release, first subjects have been enrolled in this study. Mark S. Nestor, M.D., Ph.D. (Center for Clinical and Cosmetic Research in Aventura, Fla) is the principal investigator of this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top